Symbyax, Yasmin Paragraph IV Filings
This article was originally published in The Pink Sheet Daily
Executive Summary
The first ANDA with a Paragraph IV certification for Lilly's bipolar depression combination therapy Symbyax was filed Jan. 10, according to FDA's March 15 updated list of filings